BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37721678)

  • 1. Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies.
    Huang H; Lu W; Zhang X; Pan J; Cao F; Wen L
    Cell Oncol (Dordr); 2024 Apr; 47(2):383-396. PubMed ID: 37721678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas.
    Ando R; Shiraki Y; Miyai Y; Shimizu H; Furuhashi K; Minatoguchi S; Kato K; Kato A; Iida T; Mizutani Y; Ito K; Asai N; Mii S; Esaki N; Takahashi M; Enomoto A
    J Pathol; 2024 Jan; 262(1):61-75. PubMed ID: 37796386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironment.
    Zhu J; Thakolwiboon S; Liu X; Zhang M; Lubman DM
    PLoS One; 2014; 9(12):e115507. PubMed ID: 25536077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Helm O; Mennrich R; Petrick D; Goebel L; Freitag-Wolf S; Röder C; Kalthoff H; Röcken C; Sipos B; Kabelitz D; Schäfer H; Oberg HH; Wesch D; Sebens S
    PLoS One; 2014; 9(5):e94357. PubMed ID: 24797069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties.
    Barrera LN; Evans A; Lane B; Brumskill S; Oldfield FE; Campbell F; Andrews T; Lu Z; Perez-Mancera PA; Liloglou T; Ashworth M; Jalali M; Dawson R; Nunes Q; Phillips PA; Timms JF; Halloran C; Greenhalf W; Neoptolemos JP; Costello E
    Cancer Res; 2020 Jul; 80(13):2861-2873. PubMed ID: 32393661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.
    Zheng L; Xue J; Jaffee EM; Habtezion A
    Gastroenterology; 2013 Jun; 144(6):1230-40. PubMed ID: 23622132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
    Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
    Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRABP2 and FABP5 expression levels in diseased and normal pancreas.
    Hughes CS; ChinAleong JA; Kocher HM
    Ann Diagn Pathol; 2020 Aug; 47():151557. PubMed ID: 32593808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma.
    Iwasaki T; Hiraoka N; Ino Y; Nakajima K; Kishi Y; Nara S; Esaki M; Shimada K; Katai H
    Cancer Sci; 2019 Apr; 110(4):1491-1502. PubMed ID: 30776178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
    Luong T; Golivi Y; Nagaraju GP; El-Rayes BF
    Cytokine Growth Factor Rev; 2022 Dec; 68():107-115. PubMed ID: 36096869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
    Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
    Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen.
    Ogawa Y; Masugi Y; Abe T; Yamazaki K; Ueno A; Fujii-Nishimura Y; Hori S; Yagi H; Abe Y; Kitago M; Sakamoto M
    Clin Cancer Res; 2021 Jan; 27(1):107-119. PubMed ID: 33046515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S; Qin H; Liu K; Wang H; Bai S; Liu S; Shao Z; Zhang Y; Song B; Xu X; Shen J; Zeng P; Shi X; Chen H; Gao S; Xu J; Pan Y; Xiong L; Li F; Zhang D; Jiao X; Jin G
    Clin Transl Med; 2021 Sep; 11(9):e520. PubMed ID: 34586739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer.
    Logsdon CD; Ji B
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S40-3. PubMed ID: 19896097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
    Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
    Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
    Campa D; Pastore M; Capurso G; Hackert T; Di Leo M; Izbicki JR; Khaw KT; Gioffreda D; Kupcinskas J; Pasquali C; Macinga P; Kaaks R; Stigliano S; Peeters PH; Key TJ; Talar-Wojnarowska R; Vodicka P; Valente R; Vashist YK; Salvia R; Papaconstantinou I; Shimizu Y; Valsuani C; Zambon CF; Gazouli M; Valantiene I; Niesen W; Mohelnikova-Duchonova B; Hara K; Soucek P; Malecka-Panas E; Bueno-de-Mesquita HBA; Johnson T; Brenner H; Tavano F; Fogar P; Ito H; Sperti C; Butterbach K; Latiano A; Andriulli A; Cavestro GM; Busch ORC; Dijk F; Greenhalf W; Matsuo K; Lombardo C; Strobel O; König AK; Cuk K; Strothmann H; Katzke V; Cantore M; Mambrini A; Oliverius M; Pezzilli R; Landi S; Canzian F
    Int J Cancer; 2018 Jan; 142(2):290-296. PubMed ID: 28913878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties.
    Rubiano A; Delitto D; Han S; Gerber M; Galitz C; Trevino J; Thomas RM; Hughes SJ; Simmons CS
    Acta Biomater; 2018 Feb; 67():331-340. PubMed ID: 29191507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.